ZELBORAF Access Solutions can conduct a benefits investigation
(BI) to help you determine if a Genentech medicine is covered, if
prior authorizations (PAs) are required, which specialty pharmacy (SP)
the health insurance plan prefers and if patient assistance might be
Potential outcomes of a BI:
- Treatment is covered
- PA is required
- Treatment is denied
Both the Prescriber Service Form and the Patient Consent Form must be received before ZELBORAF Access Solutions can begin helping your patient.
ZELBORAF Access Solutions can help you identify if a prior
authorization (PA) is necessary and offer resources as you obtain it
for your patient. Both the Prescriber Service Form and the Patient
Consent Form must be received before ZELBORAF Access Solutions can
begin helping your patient.
If your patient’s request for a PA is not granted, your BioOncology Field Reimbursement Manager (BFRM) or ZELBORAF Access Solutions Specialist can work with you to determine your next steps. You can find more tips like this in Forms and Documents.
The completion and submission of coverage- or reimbursement-related
documentation are the responsibility of the patient and health care
provider. Genentech makes no representation or guarantee concerning
coverage or reimbursement for any service or item.